Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

Danielle Fishel said she is feeling positive about her health while speaking exclusively with PEOPLE at iHeartRadio's 102.7 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

The actress was diagnosed with ductal carcinoma in situ (DCIS), an early stage of breast cancer, in August last year. She ...

At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask ...

FDA approval moves trastuzumab deruxtecan in combination with pertuzumab into frontline treatment of unresectable or ...

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a ...

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Danielle Fishel shared that following the completion of her breast cancer treatment, she's feeling healthy and positive ...

AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.